Home
Justin Chakma, Chief Business Officer: ARS Pharmaceuticals SPRY Sell · Filed 24/11/27
Trade details
- Type
- Insider sale
- Amount
- $592,713.3
- Shares · price
- 42,186 sh · $14.05 a share
- Held after
- 161,380 sh
- Trade date
- 24/11/26
- Filed
- 24/11/27
- Days to filing
- 1 days
Sold 20.7% of holdings
- Share of holding sold
- 20.7%
ARS Pharmaceuticals trades, last 26 weeks
What else happened in ARS Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/10/27~24/12/26Justin Chakma's recent trades
- Justin Chakma
SellARS Pharmaceuticals
SellARS Pharmaceuticals
SPRY
$1.2M
136,380 sh
$1.2M
Filed 25/11/14
Traded 25/11/12
- Justin Chakma
SellARS Pharmaceuticals
SellARS Pharmaceuticals
SPRY
$267.3K
30,000 sh
$267.3K
Filed 25/11/14
Traded 25/11/12
- Justin Chakma
Planned saleARS Pharmaceuticals
Planned saleARS Pharmaceuticals
SPRY
$267.4K
30,000 sh
$267.4K
Filed 25/11/12
Traded 25/11/12
- Justin Chakma
Planned saleARS Pharmaceuticals
Planned saleARS Pharmaceuticals
SPRY
$1.2M
138,380 sh
$1.2M
Filed 25/11/12
Traded 25/11/12
- Justin Chakma
SellARS Pharmaceuticals
SellARS Pharmaceuticals
SPRY
$1.4M
117,333 sh
$1.4M
Filed 24/12/13
Traded 24/12/12